Douglas Loe
Stock Analyst at Leede Financial
(4.64)
# 888
Out of 4,683 analysts
154
Total ratings
47%
Success rate
22.6%
Average return
Main Sectors:
Stocks Rated by Douglas Loe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $22.21 | $13.08 | +69.77% | 3 | Mar 11, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Reiterated: Buy | $3.00 | $0.28 | +990.91% | 3 | Mar 8, 2026 | |
| TSXV: NSCI Nanalysis Scientific Corp. | Maintained: Buy | $0.50 | $0.11 | +354.55% | 1 | Nov 27, 2025 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $8.5 → $4 | $0.8556 | +367.51% | 18 | Nov 25, 2025 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Maintained: Buy | $6.25 → $15.27 | $2.97 | n/a | 5 | Aug 8, 2025 | |
| PMN ProMIS Neurosciences | Maintained: Buy | n/a | $14.46 | n/a | 2 | Jul 22, 2025 | |
| TSX: DR Medical Facilities Corporation | Maintained: Buy | $4.50 → $15.50 | $15.73 | n/a | 7 | Aug 7, 2024 | |
| TSX: SVA Sernova Biotherapeutics Inc | Maintained: Buy | $3.30 → $4.58 | $0.11 | n/a | 9 | Jun 30, 2023 | |
| TSX: EXE Extendicare Inc. | Maintained: Hold | $8.25 → $7.00 | $31.68 | n/a | 13 | May 8, 2023 | |
| IMVIF IMV Inc. | Reiterated: Buy | $7.57 → $43 | $0.000016 | n/a | 18 | Apr 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $0.25 | $0.02 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.01 → $0.11 | $2.15 | n/a | 12 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.6 | $0.0001 | n/a | 13 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.00 | $3.22 | n/a | 12 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27.00 → $29.00 | $46.48 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $14.10 | n/a | 17 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37.50 | $9.90 | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.000001 | n/a | 2 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $1 | $5.19 | n/a | 4 | Oct 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.000001 | n/a | 2 | Mar 19, 2013 |
Satellos Bioscience Inc.
Mar 11, 2026
Maintained: Buy
Price Target: $22.21
Current: $13.08
Upside: +69.77%
Perimeter Medical Imaging AI, Inc.
Mar 8, 2026
Reiterated: Buy
Price Target: $3.00
Current: $0.28
Upside: +990.91%
Nanalysis Scientific Corp.
Nov 27, 2025
Maintained: Buy
Price Target: $0.50
Current: $0.11
Upside: +354.55%
Oncolytics Biotech
Nov 25, 2025
Maintained: Buy
Price Target: $8.5 → $4
Current: $0.8556
Upside: +367.51%
Cardiol Therapeutics Inc.
Aug 8, 2025
Maintained: Buy
Price Target: $6.25 → $15.27
Current: $2.97
Upside: n/a
ProMIS Neurosciences
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $14.46
Upside: n/a
Medical Facilities Corporation
Aug 7, 2024
Maintained: Buy
Price Target: $4.50 → $15.50
Current: $15.73
Upside: n/a
Sernova Biotherapeutics Inc
Jun 30, 2023
Maintained: Buy
Price Target: $3.30 → $4.58
Current: $0.11
Upside: n/a
Extendicare Inc.
May 8, 2023
Maintained: Hold
Price Target: $8.25 → $7.00
Current: $31.68
Upside: n/a
IMV Inc.
Apr 12, 2022
Reiterated: Buy
Price Target: $7.57 → $43
Current: $0.000016
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $2.75 → $0.25
Current: $0.02
Upside: n/a
Aug 31, 2020
Downgraded: Sell
Price Target: $1.01 → $0.11
Current: $2.15
Upside: n/a
Aug 27, 2020
Maintained: Buy
Price Target: $3.6
Current: $0.0001
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $7.00
Current: $3.22
Upside: n/a
Aug 14, 2020
Maintained: Hold
Price Target: $27.00 → $29.00
Current: $46.48
Upside: n/a
Aug 13, 2020
Maintained: Buy
Price Target: $3.00
Current: $14.10
Upside: n/a
Aug 7, 2020
Maintained: Buy
Price Target: $37.50
Current: $9.90
Upside: n/a
Jun 16, 2020
Maintained: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 7, 2019
Downgraded: Hold
Price Target: $34 → $1
Current: $5.19
Upside: n/a
Mar 19, 2013
Maintained: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a